Cargando…
Fine Mapping the Spatial Distribution and Concentration of Unlabeled Drugs within Tissue Micro-Compartments Using Imaging Mass Spectrometry
Readouts that define the physiological distributions of drugs in tissues are an unmet challenge and at best imprecise, but are needed in order to understand both the pharmacokinetic and pharmacodynamic properties associated with efficacy. Here we demonstrate that it is feasible to follow the in vivo...
Autores principales: | Nilsson, Anna, Fehniger, Thomas E., Gustavsson, Lena, Andersson, Malin, Kenne, Kerstin, Marko-Varga, György, Andrén, Per E. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2904372/ https://www.ncbi.nlm.nih.gov/pubmed/20644728 http://dx.doi.org/10.1371/journal.pone.0011411 |
Ejemplares similares
-
Analytical Validation Considerations
of Multiplex
Mass-Spectrometry-Based Proteomic Platforms for Measuring Protein
Biomarkers
por: Boja, Emily S., et al.
Publicado: (2014) -
Localization of tamoxifen in human breast cancer tumors by MALDI mass spectrometry imaging
por: Végvári, Ákos, et al.
Publicado: (2016) -
Moving towards high density clinical signature studies with a human proteome catalogue developing multiplexing mass spectrometry assay panels
por: Rezeli, Melinda, et al.
Publicado: (2011) -
Monitoring targeted drug delivery: a key cornerstone of precision medicine
por: Marko-Varga, György, et al.
Publicado: (2012) -
Building the basis for proteomics in personalized medicine for targeted treatment
por: Kwon, Ho Jeong, et al.
Publicado: (2016)